AVID100 in Advanced Epithelial Carcinomas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nehal Lakhani, MD
START Midwest
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Yale
New Haven, Connecticut, United States
- Start Midwest
Grand Rapids, Michigan, United States
- the Tisch Cancer Institute-Mt. Sinai
New York, New York, United States
- Fox Chase
Philadelphia, Pennsylvania, United States
- Texas Oncology Midtown
Austin, Texas, United States
- Texas Oncology-Baylor -Charles A. Sammons Cancer Center
Dallas, Texas, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- Texas Oncology Mcallen
McAllen, Texas, United States
- Texas Oncology Ne San Antonio
San Antonio, Texas, United States
- Texas Oncology Tyler
Tyler, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Feb 2017
- Primary completion
- 28 Nov 2020
- Completion
- 30 Jan 2021
- Last update posted
- 11 Jun 2025
- Registered enrollment
- 49
- Registry id
- NCT03094169
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.